Sage Journals: Discover world-class research

Open access

Review article

First published 2022-2

Expanding the Role of the Pharmacist: Immunoglobulin Therapy and Disease Management in Neuromuscular Disorders

Eric M. Tichy, Barbara Prosser, Drew Doyle

Journal of Pharmacy Practice

Free access

Review article

First published 2016-7

Subcutaneous immunoglobulins in the treatment of chronic immune-mediated neuropathies

Verena I. Leussink, Hans-Peter Hartung, Bernd C. Kieseier [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2021

Switch from intravenous to subcutaneous immunoglobulin IgPro20 in CIDP patients: a prospective observational study under real-world conditions

Stefan Gingele, Moritz Koch, Anna Christina Saparilla [...]

Therapeutic Advances in Neurological Disorders

Free access

Research article

First published 2015-1

Switch from intravenous to subcutaneous immunoglobulin in CIDP and MMN: improved tolerability and patient satisfaction

Robert D. M. Hadden, Fabrizio Marreno

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2017

Pneumococcal Antibody Titers

Pamella F. Abghari, Pavadee Poowuttikul, Elizabeth Secord

Sage Open Pediatrics

Retricted access

Brief report

First published 2019-06

Subcutaneous Immunoglobulin Twenty Percent Every Two Weeks in Pediatric Patients with Primary Immunodeficiencies: Subcohort Analysis of the IBIS Study

Clementina Canessa, Vera Gallo, Claudio Pignata [...]

Pediatric Allergy,Immunology,and Pulmonology

Free access

Research article

First published 2018-10

Assessment of renal function in patients with myositis and treated with subcutaneous immunoglobulin: a series of 24 cases

Patrick Cherin, Abir Tadmouri, Christophe de Jaeger [...]

Therapeutic Advances in Musculoskeletal Disease

Retricted access

Research article

First published 2006-2

The need for immunoglobulins

Edward Hutt

Pharmaceuticals Policy and Law

Open access

Research article

First published 2023-09-08

Standardized Tapering off Subcutaneous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy

Lars K. Markvardsen, Søren H. Sindrup, Ingelise Christiansen [...]

Journal of Neuromuscular Diseases

Open access

Letter

First published 2017-3

Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies

Clementina Canessa, Jessica Iacopelli, Antonio Pecoraro [...]

International Journal of Immunopathology and Pharmacology

Search results